spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

On Helix 2018

On_Helix_2018

10-11 July 2018
The Cambridge Building, Babraham Research Campus

ON Helix is One Nucleus' translational research conference for the Life Sciences industry.

ON Helix is a two-day event aimed at informing delegates of how to turn early stage inventions and ideas into innovative health treatments (new medicines, novel biomarkers, useful medical devices or improved medical practices).

The annual translational research conference, ON Helix aims to inform delegates of how to turn early stage inventions and ideas into innovative health treatments such as new medicines, novel biomarkers and medical devices, all aimed at improving medical practice. 

One Nucleus’ flagship Cambridge conference has moved to the Babraham Research Campus and is now a two day event. The growth of the conference allows for greater opportunities to debate the key challenges along the journey from discovery to first in man. 

Keynote Sessions will kick off both days. Each day will then break off into three parallel streams, consisting of panel debates, case studies, deal showcases, scientific talks and fireside chats. Day One will culminate with a Plenary Session and Conference Drinks Reception, open to ALL conference delegates. A great opportunity to meet those that may otherwise be attending a different day!  

Full details of the conference can be found at onhelix.com

phone +44 (0) 1223 896 450
email info@onenucleus.com
web onenucleus.com
email The Cambridge Building, Babraham Research Campus
 
Print this page
Send to a friend
   
spacer
Industry Events

PDA Universe of Pre-Filled Syringes and Injection Devices

8 October - 9 November 2018, Loews Royal Pacific, Orlando, FL

At the 2018 PDA Universe of Pre-filled Syringes and Injection Devices,industry and regulatory experts will share experiences, new developments, regulatory considerations, challenges, and industry trends and best practices. This is a must-attend event for all industry professionals involved in the development, manufacturing, testing, or marketing of pre-filled syringes and injection devices.
More info >>

White Papers

Autoinjectors From Planning to Launch

SHL Group

Looking at the rising trend towards self-administration therapies, injectable drug delivery devices such as pen injectors, autoinjectors and needle free injectors show a significant growth potential in the near future. In 2010, the pen systems and autoinjectors market was estimated to be worth over $0.58bn, a growth of 8-10% from previous years. It is estimated that the market will continue to grow steadily between 10-15% over the forecast period. It will reach $0.87bn in 2013 and $1.07bn in 2015. (Visiongain, June, 2011)
More info >>


News and Press Releases

Aptus Clinical enters into a global partnership agreement with Artelo Biosciences

We are delighted to announce that Aptus Clinical has entered into an agreement with Artelo Biosciences to provide clinical development support the re-purposing of its high-potency dual cannabinoid agonist ART27.13 in oncology.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement